Ranbaxy Laboratories gets USFDA nod to sell cholesterol medicine

Ranbaxy received approval from USFDA to manufacture & market Fenofibrate capsules used for lowering high cholesterol & triglyceride levels in blood.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news